ImmunityBio
IBRX
IBRX
104 hedge funds and large institutions have $155M invested in ImmunityBio in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 21 closing their positions.
Holders
104
Holders Change
+9
Holders Change %
+9.47%
% of All Funds
1.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
32
Reduced
23
Closed
21
Calls
$9.93M
Puts
$24.1M
Net Calls
-$14.1M
Net Calls Change
-$12M
Top Buyers
1 |
1
BlackRock
New York
|
$44M |
2 |
2
Invesco
Atlanta,
Georgia
|
$4.58M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$4.3M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$27M |
5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$4.24M |